This presentation was last reviewed on June 5, 2024, and broadcast live online on September 17, 2021, from 10:45 AM - 12:15 PM ET. 
This presentation was last reviewed on May 13, 2024, and broadcast live online on October 1, 2021, from 9:00 AM - 12:15 PM ET. 
This presentation was last reviewed on May 13, 2024, and broadcast live online on January 26, 2022, from 12:00 PM - 1:00 PM ET. 
This presentation was last reviewed on December 4, 2023, broadcast live online on December 1, 2021, from 12:00 pm - 1:00 pm ET.
This presentation was last reviewed on July 10, 2024, and broadcast live online on March 26, 2021, from 10:45 AM - 12:15 PM ET.
This presentation was originally reviewed on December 13, 2023, and broadcast live online on December 13, 2023, from 12:00 PM – 1:00 PM ET.
Behavioral and Psychological Symptoms of Dementia (BPSD) refers to a group of non-cognitive symptoms and behaviors that occur commonly in patients with dementia. They result from a complex interplay between various biological, psychological and social factors involved in the disease process. BPSD is associated with increased caregiver burden, institutionalization, a more rapid decline in cognition and function and overall poorer quality of life. It also adds to the direct and indirect costs of caring for patients with dementia. Available data indicate efficacy for some non-pharmacological and pharmacological treatment modalities for BPSD. However, recently the use of psychotropic medications for the treatment of BPSD has generated controversy due to increased recognition of their serious adverse effects.
This presentation was originally reviewed on May 3, 2023, and broadcast live online on May 3, 2023, from 12:00 PM – 1:00 PM ET.
This presentation will explore the relational aspects of psychopharmacological work with youth and families. While technical and scientific knowledge can be taught and examined during medical education, the therapeutic skills also known as “nonspecific” treatment factors or “common factors” are more elusive and harder to describe. Differences in culture between the prescriber and the patient often lead to differing perspectives and, if not explored, can interfere with the treatment alliance and subsequently with treatment adherence and/or resistance. Cultural concordance is crucial to teach physicians how to appreciate the cultural background unique to each patient in a way that values and honors our similarities and our differences. In keeping with the adage, The formulation must always precede the prescription, recent work has highlighted the use of the DSM-5 Cultural Formulation Interview as an important tool to more fully understand a young person in the context of their daily life, as part of comprehensive treatment planning. We propose that the term ‘med check’ is not only a misnomer that simply doesn’t exist in child and adolescent psychiatric treatment (as if the patient just comes to us wanting to ‘talk about their meds’), but more importantly it is a disservice to the nature and intention of our work with youth and families. For such time-limited visits where the medication issues are a primary focus, we propose the term, ‘brief pharmacotherapy visits’, which allows us to retain our role as therapists (as an inextricable part of psychopharmacology). An effective pharmacotherapy appointment necessitates the appreciation of many things that inform treatment, and thus pharmacotherapy decisions, including the intricacies of an individual’s culturally informed, biopsychosocial story. It has consistently been shown that strong therapeutic alliances between a patient and their mental health provider, as well as empathy demonstrated by the latter, lead to more positive clinical and functional outcomes- and thus to the primary goal of evaluating and promoting mental health and well-being.
This presentation was originally reviewed on September 29, 2023, and broadcast live online on July 22, 2020 from 12:00 PM- 1:00 PM ET. 

Pages

Subscribe to RSS - Psychopharmacology